Eprosartan Mesylate Hydrochlorothiazide

This page contains recent news articles, when available, and an overview of Eprosartan Mesylate Hydrochlorothiazide but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Kos Enters Cardio Area, Gets Biovail Products For $104M  -  May 4, 2005
By Karen Pihl-Carey. Getting a stronger foothold in the cardiovascular therapeutic area, Kos Pharmaceuticals Inc. paid $104 million in cash to Biovail Corp. ... BioWorld Online - BioWorld Online

Kos enters cardiovascular R&D alliance with Biovail.(Kos …  -  May 2, 2005
US firm Kos Pharmaceuticals has entered into a strategic commercialization and R&D alliance with Canada's Biovail Corp under which it will acquire products ... $4.95 - Pharma Marketletter - ECNext

Kos Reports 49% Increase in Revenue to $179.4 Million, Earnings Per …  -  Aug 4, 2005
Kos Pharmaceuticals, Inc. (Nasdaq: KOSP) today announced financial results for the second quarter and six months ended June 30, 2005. ... $4.95 - Business Wire - ECNext

Federal Register 2008 - 73 FR 51829 Publication of Guidances for …  -  Sep 5, 2008
73 FR 51829 Publication of Guidances for Industry Describing Product-Specific Bioequivalence Recommendations September 5, 2008 [Docket No. ... Pay-Per-View - Federal Register 2008 - Loislaw

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.